EP1037927B1
(de)
|
1997-12-08 |
2004-05-19 |
Lexigen Pharmaceuticals Corp. |
Heterodimäre fusionsproteine zur verwendung für gezielte immuntherapie und allgemeine immunerregung
|
US20030105294A1
(en)
*
|
1998-02-25 |
2003-06-05 |
Stephen Gillies |
Enhancing the circulating half life of antibody-based fusion proteins
|
JP2002511432A
(ja)
*
|
1998-04-15 |
2002-04-16 |
レキシジェン ファーマシューティカルズ コーポレイション |
新脈管形成インヒビターの同時投与による抗体−サイトカイン融合タンパク質媒介性免疫応答の増強
|
US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
US7345019B1
(en)
*
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
CZ299516B6
(cs)
*
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
MXPA02001417A
(es)
*
|
1999-08-09 |
2002-08-12 |
Lexigen Pharm Corp |
Complejos multiples de citosina-anticuerpo.
|
US20050202538A1
(en)
*
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
AU4314801A
(en)
*
|
2000-02-11 |
2001-08-20 |
Lexigen Pharm Corp |
Enhancing the circulating half-life of antibody-based fusion proteins
|
US6586398B1
(en)
*
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
DK1311285T4
(en)
†
|
2000-05-15 |
2017-07-24 |
Hoffmann La Roche |
Liquid pharmaceutical composition containing an erythropoietin derivative
|
CN1270775C
(zh)
*
|
2000-06-29 |
2006-08-23 |
默克专利有限公司 |
通过与免疫细胞因子摄入促进剂联合治疗来增强抗体-细胞因子融合蛋白介导的免疫反应
|
EP1333036B1
(de)
*
|
2000-10-16 |
2009-01-21 |
Chugai Seiyaku Kabushiki Kaisha |
Peg-modifiziertes erythropoietin
|
WO2002049673A2
(en)
*
|
2000-12-20 |
2002-06-27 |
F. Hoffmann-La Roche Ag |
Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
|
CN100528235C
(zh)
*
|
2000-12-20 |
2009-08-19 |
霍夫曼-拉罗奇有限公司 |
红细胞生成素共轭物
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
EP1234583A1
(de)
*
|
2001-02-23 |
2002-08-28 |
F. Hoffmann-La Roche Ag |
PEG-Konjugate des HGF-NK4
|
KR100900176B1
(ko)
*
|
2001-03-07 |
2009-06-02 |
메르크 파텐트 게엠베하 |
하이브리드 이소타입 항체 부분구조를 포함하는 단백질을위한 발현 기술
|
DE10112825A1
(de)
|
2001-03-16 |
2002-10-02 |
Fresenius Kabi De Gmbh |
HESylierung von Wirkstoffen in wässriger Lösung
|
US6992174B2
(en)
*
|
2001-03-30 |
2006-01-31 |
Emd Lexigen Research Center Corp. |
Reducing the immunogenicity of fusion proteins
|
DK1383785T3
(da)
*
|
2001-05-03 |
2011-05-23 |
Merck Patent Gmbh |
Rekombinant tumorspecifikt antistof og anvendelse deraf
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
KR100467751B1
(ko)
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
AU2002357784B2
(en)
|
2001-12-04 |
2008-07-31 |
Merck Patent Gmbh |
Immunocytokines with modulated selectivity
|
WO2003053997A2
(en)
*
|
2001-12-06 |
2003-07-03 |
Fibrogen, Inc. |
Methods of increasing endogenous erythropoietin (epo)
|
DE10209821A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung von Proteinen an ein modifiziertes Polysaccharid
|
DE10209822A1
(de)
|
2002-03-06 |
2003-09-25 |
Biotechnologie Ges Mittelhesse |
Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
|
WO2003078959A2
(en)
|
2002-03-11 |
2003-09-25 |
Ortho Mcneil Pharmaceutical, Inc |
Methods for shp1 mediated neuroprotection
|
WO2004003176A2
(en)
*
|
2002-07-01 |
2004-01-08 |
The Kenneth S. Warren Institute, Inc. |
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
|
PL375265A1
(en)
|
2002-07-24 |
2005-11-28 |
F.Hoffmann-La Roche Ag |
Polyalkylene glycol acid additives
|
US7459435B2
(en)
*
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
US20050176627A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Anthony Cerami |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
ATE466085T1
(de)
*
|
2002-09-09 |
2010-05-15 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
BR0314227A
(pt)
|
2002-09-11 |
2005-10-25 |
Fresenius Kabi De Gmbh |
Derivados de amido de hidroxialquila
|
US7459436B2
(en)
*
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
US7388079B2
(en)
*
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
PT1572748E
(pt)
*
|
2002-12-17 |
2010-09-28 |
Merck Patent Gmbh |
Anticorpo humanizado (h14.18) do anticorpo 14.18 de rato que se liga ao gd2 e a sua fusão com a il-2
|
US7553930B2
(en)
|
2003-01-06 |
2009-06-30 |
Xencor, Inc. |
BAFF variants and methods thereof
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
US7587286B2
(en)
|
2003-03-31 |
2009-09-08 |
Xencor, Inc. |
Methods for rational pegylation of proteins
|
US7610156B2
(en)
|
2003-03-31 |
2009-10-27 |
Xencor, Inc. |
Methods for rational pegylation of proteins
|
US7642340B2
(en)
|
2003-03-31 |
2010-01-05 |
Xencor, Inc. |
PEGylated TNF-α variant proteins
|
US7279174B2
(en)
*
|
2003-05-08 |
2007-10-09 |
Advanced Cardiovascular Systems, Inc. |
Stent coatings comprising hydrophilic additives
|
NZ543934A
(en)
|
2003-05-12 |
2008-06-30 |
Affymax Inc |
Novel spacer moiety for poly (ethylene glycol)-modified peptide-based compounds
|
EA010095B1
(ru)
|
2003-05-12 |
2008-06-30 |
Афимакс, Инк. |
Новые пептиды, которые связываются с рецептором эритропоэтина
|
EP1625156B1
(de)
*
|
2003-05-12 |
2012-09-19 |
Affymax, Inc. |
An den erythropoietinrezeptor bindenden peptiden
|
US20050107297A1
(en)
*
|
2003-05-12 |
2005-05-19 |
Holmes Christopher P. |
Novel poly(ethylene glycol) modified compounds and uses thereof
|
CN1826131A
(zh)
*
|
2003-05-30 |
2006-08-30 |
森托科尔公司 |
利用转谷氨酰胺酶形成新的促红细胞生成素缀合物
|
WO2005011587A2
(en)
*
|
2003-07-30 |
2005-02-10 |
New Century Pharmaceuticls |
Chalaropsis lysozyme protein and its method of use in anti-bacterial applications
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
US7645733B2
(en)
*
|
2003-09-29 |
2010-01-12 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
|
WO2005035564A2
(en)
|
2003-10-10 |
2005-04-21 |
Xencor, Inc. |
Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
|
CN1901934B
(zh)
*
|
2003-12-19 |
2013-09-11 |
弗·哈夫曼-拉罗切有限公司 |
促红细胞生成素在治疗慢性炎症性肠病中铁分布紊乱中的用途
|
EP1548031A1
(de)
*
|
2003-12-22 |
2005-06-29 |
Dubai Genetics FZ-LLC |
Naturidentischer Erythropoietin
|
CA2551916C
(en)
*
|
2003-12-31 |
2014-04-29 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
CA2553528C
(en)
*
|
2004-01-21 |
2012-12-04 |
Nektar Therapeutics Al, Corporation |
Method of preparing propionic acid-terminated polymers
|
ZA200606225B
(en)
*
|
2004-02-02 |
2007-11-28 |
Ambrx Inc |
Modified human four helical bundle polypeptides and their uses
|
EP1725589A1
(de)
|
2004-03-11 |
2006-11-29 |
Fresenius Kabi Deutschland GmbH |
Hydroxyalkylstärke-protein-konjugate, durch reduktive aminierung hergestellt
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
US7253650B2
(en)
|
2004-05-25 |
2007-08-07 |
International Business Machines Corporation |
Increase productivity at wafer test using probe retest data analysis
|
EP1814910A4
(de)
*
|
2004-11-11 |
2009-04-29 |
Affymax Inc |
Neue am erythropoietinrezeptor bindende peptide
|
WO2006062685A2
(en)
*
|
2004-11-11 |
2006-06-15 |
Affymax, Inc. |
Novel peptides that bind to the erythropoietin receptor
|
CA2595695A1
(en)
|
2005-01-25 |
2006-08-03 |
Cell Therapeutics, Inc. |
Biologically active protein conjugates comprising (nn[s/t]) peptide repeats and having increased plasma half-life
|
WO2006089228A2
(en)
*
|
2005-02-16 |
2006-08-24 |
Nektar Therapeutics Al, Corporation |
Conjugates of an epo moiety and a polymer
|
US8324159B2
(en)
*
|
2005-06-03 |
2012-12-04 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
US7919461B2
(en)
|
2005-06-03 |
2011-04-05 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
US7550433B2
(en)
*
|
2005-06-03 |
2009-06-23 |
Affymax, Inc. |
Erythropoietin receptor peptide formulations and uses
|
US20070072795A1
(en)
*
|
2005-09-28 |
2007-03-29 |
Anton Haselbeck |
Treatment of neurodegenerative disorders
|
ATE491722T1
(de)
*
|
2005-10-04 |
2011-01-15 |
Zymogenetics L L C |
Herstellung und reinigung von il-29
|
US8142781B2
(en)
*
|
2005-10-07 |
2012-03-27 |
Armagen Technologies, Inc. |
Fusion proteins for blood-brain barrier delivery
|
US8741260B2
(en)
*
|
2005-10-07 |
2014-06-03 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of GDNF to the CNS
|
US8124095B2
(en)
*
|
2005-10-07 |
2012-02-28 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of erythropoietin to the CNS
|
US20080171696A1
(en)
*
|
2005-10-21 |
2008-07-17 |
Avigenics, Inc. |
Pharmacodynamically enhanced therapeutic proteins
|
US20070092486A1
(en)
*
|
2005-10-21 |
2007-04-26 |
Avigenics, Inc. |
Glycolated and glycosylated poultry derived therapeutic proteins
|
US8841255B2
(en)
|
2005-12-20 |
2014-09-23 |
Duke University |
Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
|
US8178495B2
(en)
|
2008-06-27 |
2012-05-15 |
Duke University |
Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide
|
US20130172274A1
(en)
*
|
2005-12-20 |
2013-07-04 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
WO2007100905A2
(en)
*
|
2006-02-28 |
2007-09-07 |
Nexgen Therapeutics, Llc |
Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
|
EP1997505A4
(de)
|
2006-03-22 |
2013-02-13 |
Chugai Pharmaceutical Co Ltd |
Zubereitung einer erythropoetinlösung
|
ES2529234T3
(es)
*
|
2006-08-04 |
2015-02-18 |
Prolong Pharmaceuticals, LLC |
Eritropoyetina modificada
|
JP5959795B2
(ja)
|
2006-08-18 |
2016-08-02 |
アーメイゲン・テクノロジーズ・インコーポレイテッドArmagen Technologies, Inc. |
血液脳関門送達のための物質
|
EP2120998B1
(de)
*
|
2006-11-28 |
2013-08-07 |
HanAll Biopharma Co., Ltd. |
Modifizierte erythropoetin-polypeptide und ihre verwendungen zur behandlung
|
JP2010517529A
(ja)
*
|
2007-02-02 |
2010-05-27 |
アムジエン・インコーポレーテツド |
ヘプシジン及びヘプシジン抗体
|
WO2008137066A1
(en)
*
|
2007-05-02 |
2008-11-13 |
The Board Of Regents Of The University Of Oklahoma |
Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
|
CL2008002053A1
(es)
*
|
2007-07-17 |
2009-05-22 |
Hoffmann La Roche |
Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
|
CL2008002054A1
(es)
*
|
2007-07-17 |
2009-05-29 |
Hoffmann La Roche |
Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
|
CA2694762A1
(en)
|
2007-07-27 |
2009-02-05 |
Armagen Technologies, Inc. |
Methods and compositions for increasing alpha-l-iduronidase activity in the cns
|
EP2205280B1
(de)
|
2007-09-27 |
2019-09-04 |
Amgen Inc. |
Pharmazeutische formulierungen
|
US8796206B2
(en)
|
2007-11-15 |
2014-08-05 |
Amgen Inc. |
Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
|
EP2669313B1
(de)
|
2008-01-11 |
2016-03-23 |
Serina Therapeutics, Inc. |
Multifunktionsformen von Polyoxazolincopolymeren und Wirkstoffzusammensetzungen damit
|
US8101706B2
(en)
|
2008-01-11 |
2012-01-24 |
Serina Therapeutics, Inc. |
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
|
WO2009094551A1
(en)
|
2008-01-25 |
2009-07-30 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
CN103694337B
(zh)
|
2008-02-08 |
2016-03-02 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
TWI395593B
(zh)
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
WO2009128917A2
(en)
|
2008-04-14 |
2009-10-22 |
Halozyme, Inc. |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
|
EP2816059A1
(de)
|
2008-05-01 |
2014-12-24 |
Amgen, Inc |
Anti-Hepcidin-Antikörper und Verfahren zu ihrer Verwendung
|
AU2009296397B2
(en)
|
2008-09-26 |
2012-11-08 |
Ambrx Inc. |
Modified animal erythropoietin polypeptides and their uses
|
CA2742871C
(en)
|
2008-11-13 |
2018-10-23 |
Herb Lin |
Methods and compositions for regulating iron homeostasis by modulation of bmp-6
|
US8927249B2
(en)
|
2008-12-09 |
2015-01-06 |
Halozyme, Inc. |
Extended soluble PH20 polypeptides and uses thereof
|
CA2748889A1
(en)
|
2009-03-18 |
2010-09-23 |
Armagen Technologies, Inc. |
Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins
|
PL2459291T3
(pl)
|
2009-07-30 |
2018-07-31 |
F.Hoffmann-La Roche Ag |
Ruchomy chromatograficzny rozdzielacz kolumnowy
|
WO2011024025A1
(en)
*
|
2009-08-28 |
2011-03-03 |
Avesthagen Limited |
An erythropoietin analogue and a method thereof
|
JP5734985B2
(ja)
|
2009-09-17 |
2015-06-17 |
バクスター・ヘルスケヤー・ソシエテ・アノニムBaxter Healthcare SA |
ヒアルロニダーゼおよび免疫グロブリンの安定な共製剤およびそれらの使用方法
|
CA2775012A1
(en)
*
|
2009-09-23 |
2011-03-31 |
Biogenerix Ag |
Process for the purification of recombinant human erythropoietin (epo), epo thus purified and pharmaceutical compositions comprising same
|
HUE044865T2
(hu)
*
|
2009-10-09 |
2019-11-28 |
Armagen Inc |
Eljárások és készítmények a központi idegrendszerben iduronát-2-szulfatáz-aktivitás növelésére
|
CA2778105C
(en)
|
2009-10-23 |
2019-04-02 |
Amgen Inc. |
Vial adapter and system
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
KR101880905B1
(ko)
*
|
2010-04-27 |
2018-07-23 |
에스씨아이엘 테크놀로지 게엠베하 |
안정한 수성 mia/cd-rap 제제
|
AU2011265005B2
(en)
|
2010-06-07 |
2015-04-09 |
Amgen Inc. |
Drug delivery device
|
ES2661089T3
(es)
|
2010-07-20 |
2018-03-27 |
Halozyme Inc. |
Métodos de tratamiento o prevención de los efectos secundarios adversos asociados con la administración de un agente anti-hialuronano
|
WO2012035037A1
(en)
|
2010-09-14 |
2012-03-22 |
F. Hoffmann-La Roche Ag |
Method for purifying pegylated erythropoietin
|
MX347297B
(es)
|
2011-02-02 |
2017-04-21 |
Hoffmann La Roche |
Soporte para columna de cromatografía.
|
WO2012109387A1
(en)
|
2011-02-08 |
2012-08-16 |
Halozyme, Inc. |
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
|
CA2831100C
(en)
|
2011-03-31 |
2020-02-18 |
Mark Dominis Holt |
Vial adapter and system
|
EP4074355A1
(de)
|
2011-04-20 |
2022-10-19 |
Amgen Inc. |
Autoinjektorvorrichtung
|
US9993529B2
(en)
|
2011-06-17 |
2018-06-12 |
Halozyme, Inc. |
Stable formulations of a hyaluronan-degrading enzyme
|
CA2851521C
(en)
|
2011-10-14 |
2020-09-22 |
Amgen Inc. |
Injector and method of assembly
|
JP6162707B2
(ja)
|
2011-10-24 |
2017-07-12 |
ハロザイム インコーポレイテッド |
抗ヒアルロナン剤治療のためのコンパニオン診断およびその使用方法
|
US8486399B2
(en)
|
2011-12-02 |
2013-07-16 |
Armagen Technologies, Inc. |
Methods and compositions for increasing arylsulfatase A activity in the CNS
|
EP3130347B1
(de)
|
2011-12-30 |
2019-09-18 |
Halozyme, Inc. |
Ph20-polypeptidvarianten, formulierungen und verwendungen davon
|
US9913822B2
(en)
|
2012-04-04 |
2018-03-13 |
Halozyme, Inc. |
Combination therapy with an anti-hyaluronan agent and therapeutic agent
|
CN102816227A
(zh)
*
|
2012-08-30 |
2012-12-12 |
深圳赛保尔生物药业有限公司 |
回收促红细胞生成素的方法
|
US9278124B2
(en)
|
2012-10-16 |
2016-03-08 |
Halozyme, Inc. |
Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
|
EP2922590B1
(de)
|
2012-11-21 |
2020-02-05 |
Amgen Inc. |
Arzneimittelabgabevorrichtung
|
WO2014144096A1
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
WO2014152006A2
(en)
|
2013-03-15 |
2014-09-25 |
Intrinsic Lifesciences, Llc |
Anti-hepcidin antibodies and uses thereof
|
TWI639449B
(zh)
|
2013-03-15 |
2018-11-01 |
美商安美基公司 |
用於注射器之匣盒
|
AU2014238267B2
(en)
|
2013-03-22 |
2019-08-15 |
Amgen Inc. |
Injector and method of assembly
|
TW201534726A
(zh)
|
2013-07-03 |
2015-09-16 |
Halozyme Inc |
熱穩定ph20玻尿酸酶變異體及其用途
|
EP3041513B1
(de)
|
2013-09-08 |
2020-08-05 |
Kodiak Sciences Inc. |
Zwitterionische faktor-viii-polymerkonjugate
|
CA2926110C
(en)
|
2013-10-24 |
2023-05-23 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
CA2920894C
(en)
|
2013-10-24 |
2023-03-14 |
Amgen Inc. |
Injector and method of assembly
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
EP3139977B1
(de)
|
2014-05-07 |
2021-02-17 |
Amgen Inc. |
Autoinjektor mit stossabsorbierenden elementen
|
WO2015187802A1
(en)
|
2014-06-03 |
2015-12-10 |
Amgen Inc. |
Devices and methods for assisting a user of a drug delivery device
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
PL3186281T3
(pl)
|
2014-08-28 |
2019-10-31 |
Halozyme Inc |
Terapia skojarzona enzymem rozkładającym hialuronian i inhibitorem punktu kontrolnego odpowiedzi immunologicznej
|
US10323088B2
(en)
|
2014-09-22 |
2019-06-18 |
Intrinsic Lifesciences Llc |
Humanized anti-hepcidin antibodies and uses thereof
|
BR112017007765B1
(pt)
|
2014-10-14 |
2023-10-03 |
Halozyme, Inc |
Composições de adenosina deaminase-2 (ada2), variantes do mesmo e métodos de usar o mesmo
|
EP3943135A3
(de)
|
2014-10-14 |
2022-06-29 |
Amgen Inc. |
Arzneimittelinjektionsvorrichtung mit visuellen und hörbaren indikatoren
|
WO2016061562A2
(en)
|
2014-10-17 |
2016-04-21 |
Kodiak Sciences Inc. |
Butyrylcholinesterase zwitterionic polymer conjugates
|
ES2785311T3
(es)
|
2014-12-19 |
2020-10-06 |
Amgen Inc |
Dispositivo de administración de fármacos con botón móvil o campo de interfaz de usuario
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
US10538589B2
(en)
|
2015-01-14 |
2020-01-21 |
Armagen Inc. |
Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
|
EP3556411B1
(de)
|
2015-02-17 |
2021-06-30 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit vakuumunterstützter sicherung und/oder rückkopplung
|
US11806509B2
(en)
|
2015-02-27 |
2023-11-07 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a turnable threshold of resistance to needle guard movement
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
ES2755717T3
(es)
|
2015-12-09 |
2020-04-23 |
Amgen Inc |
Autoinyector con tapa de señalización
|
US11066465B2
(en)
|
2015-12-30 |
2021-07-20 |
Kodiak Sciences Inc. |
Antibodies and conjugates thereof
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
ES2814287T3
(es)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco
|
CN105820232B
(zh)
*
|
2016-04-08 |
2019-05-17 |
昂德生物药业有限公司 |
单修饰聚乙二醇重组人促红素的制备方法及其制品和应用
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
JP7309363B2
(ja)
|
2016-05-13 |
2023-07-18 |
アムジエン・インコーポレーテツド |
バイアル・スリーブ組立体
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
WO2017209899A1
(en)
|
2016-06-03 |
2017-12-07 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
EP3478342A1
(de)
|
2016-07-01 |
2019-05-08 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit minimiertem teilebruchrisiko nach aufprallereignissen
|
CA3027143A1
(en)
|
2016-07-15 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
Method for purifying pegylated erythropoietin
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
CA3049780A1
(en)
|
2017-01-17 |
2018-07-26 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
MX2019009625A
(es)
|
2017-02-17 |
2019-10-09 |
Amgen Inc |
Dispositivo de administracion de farmacos con trayectoria de flujo de fluido esteril y metodo relacionado de ensamblaje.
|
AU2018231107B2
(en)
|
2017-03-06 |
2023-04-20 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
WO2018164829A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
MX2019010671A
(es)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Mecanismo de insercion para dispositivo de administracion de farmacos.
|
WO2018172219A1
(en)
|
2017-03-20 |
2018-09-27 |
F. Hoffmann-La Roche Ag |
Method for in vitro glycoengineering of an erythropoiesis stimulating protein
|
EA037969B1
(ru)
|
2017-03-28 |
2021-06-17 |
Эмджен Инк. |
Система и способ сборки штока поршня и шприца
|
WO2018226515A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
CN110709121B
(zh)
|
2017-06-08 |
2022-06-24 |
安进公司 |
扭矩驱动式药物递送装置
|
CA3177086A1
(en)
|
2017-06-22 |
2018-12-27 |
Catalyst Biosciences, Inc. |
Modified membrane type serine protease 1 (mtsp-1) polypeptides and methods of use
|
MA49447A
(fr)
|
2017-06-22 |
2020-04-29 |
Amgen Inc |
Réduction des impacts/chocs d'activation d'un dispositif
|
EP3641861A1
(de)
|
2017-06-23 |
2020-04-29 |
Amgen Inc. |
Elektronische arzneimittelabgabevorrichtung mit einer durch eine schaltungsanordnung aktivierten kappe
|
MA49562A
(fr)
|
2017-07-14 |
2020-05-20 |
Amgen Inc |
Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion
|
MA49626A
(fr)
|
2017-07-21 |
2020-05-27 |
Amgen Inc |
Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage
|
EP4085942A1
(de)
|
2017-07-25 |
2022-11-09 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit getriebemodul und verwandtes verfahren zur montage
|
EP3658206A1
(de)
|
2017-07-25 |
2020-06-03 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit behälterzugangssystem und zugehörigem verfahren zur montage
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
WO2019036181A1
(en)
|
2017-08-18 |
2019-02-21 |
Amgen Inc. |
BODY INJECTOR WITH STERILE ADHESIVE PATCH
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
EP4257164A3
(de)
|
2017-10-06 |
2024-01-17 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit verriegelungsvorrichtung und zugehöriges montageverfahren
|
MA50348A
(fr)
|
2017-10-09 |
2020-08-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé
|
MA50528A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Systèmes et approches pour stériliser un dispositif d'administration de médicament
|
EP3706830A1
(de)
|
2017-11-06 |
2020-09-16 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit positionierungs- und durchflussmessung
|
US20200338271A1
(en)
|
2017-11-06 |
2020-10-29 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
WO2019094138A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
CN111263651B
(zh)
|
2017-11-16 |
2022-06-17 |
安进公司 |
具有停顿和终点检测的自动注射器
|
MA50904A
(fr)
|
2017-11-16 |
2020-09-23 |
Amgen Inc |
Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament
|
SI3731872T1
(sl)
|
2017-12-29 |
2022-04-29 |
F. Hoffmann-La Roche Ag |
Postopek za zagotavljanje sestavka PEGiliranih beljakovin
|
SG11202005990RA
(en)
|
2017-12-29 |
2020-07-29 |
Hoffmann La Roche |
Process for providing pegylated protein composition
|
ES2909454T3
(es)
|
2017-12-29 |
2022-05-06 |
Hoffmann La Roche |
Procedimiento para proporcionar una composición de proteína PEGilada
|
US20190351031A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
US20210369982A1
(en)
|
2018-07-24 |
2021-12-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
MA53375A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
WO2020028009A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
DK3613486T3
(da)
*
|
2018-08-24 |
2021-01-04 |
Uga Biopharma Gmbh |
Metode og anlæg til rengøring af epo og/eller et epo-derivat
|
JP2022500095A
(ja)
|
2018-09-24 |
2022-01-04 |
アムジエン・インコーポレーテツド |
インターベンション投薬システム及び方法
|
AU2019350660A1
(en)
|
2018-09-28 |
2021-03-18 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
US20200101229A1
(en)
|
2018-10-02 |
2020-04-02 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
AR116607A1
(es)
|
2018-10-05 |
2021-05-26 |
Amgen Inc |
Dispositivo de administración de fármacos con indicador de dosis
|
BR112021007016A2
(pt)
|
2018-10-15 |
2021-07-13 |
Amgen Inc. |
dispositivo de administração de fármaco tendo mecanismo de amortecimento
|
EA202191038A1
(ru)
|
2018-10-15 |
2021-07-06 |
Эмджен Инк. |
Способ платформенной сборки для устройства доставки лекарственного средства
|
AU2019370159A1
(en)
|
2018-11-01 |
2021-04-22 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
US20220031953A1
(en)
|
2018-11-01 |
2022-02-03 |
Amgen Inc. |
Drug delivery devices with partial needle retraction
|
MA54048A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament avec rétraction partielle de l'organe d'administration de médicament
|
US11613744B2
(en)
|
2018-12-28 |
2023-03-28 |
Vertex Pharmaceuticals Incorporated |
Modified urokinase-type plasminogen activator polypeptides and methods of use
|
EP3958934A1
(de)
|
2019-04-24 |
2022-03-02 |
Amgen Inc. |
Anordnungen und verfahren zur überprüfung der sterilisation von spritzen
|
JP2022545227A
(ja)
|
2019-08-23 |
2022-10-26 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
WO2021072265A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
WO2022063082A1
(zh)
|
2020-09-22 |
2022-03-31 |
美国杰科实验室有限公司 |
一种糖基化修饰的促红细胞生成素及其应用
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
CN117279929A
(zh)
|
2021-05-10 |
2023-12-22 |
凯奥目生物科学株式会社 |
抗体组合物的纯化方法
|
AU2022279223A1
(en)
|
2021-05-21 |
2023-10-19 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
WO2023209074A1
(en)
|
2022-04-28 |
2023-11-02 |
Institut National de la Santé et de la Recherche Médicale |
Methods of restoring erythropoiesis in patients suffering from a sf3b1 mutant myelodysplastic syndrome by correcting coasy mis-splicing
|
CN116492448A
(zh)
*
|
2023-04-12 |
2023-07-28 |
深圳赛保尔生物药业有限公司 |
负载peg-epo及间充质干细胞的组合物、药物及其制备方法
|